LEGAL PROCEEDINGS - Narrative (Details) $ in Thousands, $ in Millions															1 Months Ended								4 Months Ended	12 Months Ended
	Feb. 23, 2023 defendant	Feb. 17, 2023	Jul. 21, 2022	Feb. 02, 2022	Sep. 10, 2021	Jul. 26, 2021 USD ($)	Jul. 20, 2021 USD ($) insured	Aug. 28, 2020	Aug. 04, 2020 CAD ($)	May 01, 2020	Mar. 26, 2020	Dec. 16, 2019 USD ($)	Jan. 28, 2019 USD ($)	Dec. 07, 2017 insurance_policy_period	Feb. 23, 2023 USD ($)	Jan. 31, 2023	Dec. 31, 2021 USD ($)	Nov. 30, 2021	Apr. 30, 2021	Mar. 31, 2021 defendant proceeding	Apr. 30, 2018 USD ($)	Oct. 31, 2015 case	Sep. 16, 2016 action	Dec. 31, 2022 USD ($) defendant group case action lawsuit	Dec. 31, 2021 USD ($)	Jul. 30, 2020 case	Dec. 31, 2016 case	Mar. 17, 2021 number_business	Feb. 15, 2019 entity
Legal proceedings and other matters
Legal matters and related fees | $																	$ 1,890,000							$ 326,000	$ 1,890,000
Investigation by the U.S. Attorney’s Office for the District of Massachusetts-OraPharma Litigation | Settled Litigation | Subsequent Event
Legal proceedings and other matters
Litigation, amount paid | $															$ 100
Valeant US Securities Litigation | New Jersey
Legal proceedings and other matters
Number of groups of investors | group																								37
Number of cases dismissed																								16
Number of groups of investors filing action, remain pending | group																								21
Valeant US Securities Litigation | New Jersey | Settled Litigation
Legal proceedings and other matters
Litigation, amount paid | $												$ 1,210,000													$ 1,510,000
Valeant US Securities Litigation | New Jersey | Unfavorable Regulatory Action
Legal proceedings and other matters
Recent suits filed																						4
Canadian Securities Litigation | Canada
Legal proceedings and other matters
Recent suits filed																											6
Canadian Securities Litigation | Canada | Violation of Canadian Provincial Securities Legislation
Legal proceedings and other matters
Number of additional suits filed, but not served | action																								2
Number of entities, exercised opt-out right, pursuing action																												4	1
Canadian Securities Litigation | Canada | Violation of Canadian Provincial Securities Legislation | Settled Litigation
Legal proceedings and other matters
Litigation, amount paid | $									$ 94
RICO Class Actions Litigation | New Jersey | Unfavorable Regulatory Action
Legal proceedings and other matters
Recent suits filed | action																							3
Insurance Coverage Lawsuit
Legal proceedings and other matters
Number of distinct insurance policy periods | insurance_policy_period														2
Insurance Coverage Lawsuit | Settled Litigation
Legal proceedings and other matters
Settlement agreements, number of insurers | insured							2
Aggregate amount received | $							$ 213,000
Perrigo Israel Pharmaceuticals, Ltd. Litigation
Legal proceedings and other matters
Stay of approval, period								30 months
Glumetza Antitrust Litigation
Legal proceedings and other matters
Recent suits filed																										8
Glumetza Antitrust Litigation | Plaintiffs, Direct Purchasers
Legal proceedings and other matters
Recent suits filed																										3
Glumetza Antitrust Litigation | Pending Litigation
Legal proceedings and other matters
Litigation, amount paid | $						$ 300,000
Glumetza Antitrust Litigation, Non-Class Complaints
Legal proceedings and other matters
Recent suits filed																										4
Glumetza Antitrust Litigation, Non-Class Complaints | Plaintiffs, Direct Purchasers
Legal proceedings and other matters
Recent suits filed																										3
Norwich Pharmaceuticals Inc. Litigation
Legal proceedings and other matters
Stay of approval, period											30 months
Taro Pharmaceuticals Inc. Litigation
Legal proceedings and other matters
Stay of approval, period			30 days
Padagis Litigation
Legal proceedings and other matters
Stay of approval, period										30 days
MSN Laboratories Private Ltd. Litigation
Legal proceedings and other matters
Stay of approval, period																			30 months
Aurobindo Pharma Limited Litigation | Subsequent Event
Legal proceedings and other matters
Stay of approval, period																30 months
PreserVision® AREDS Patent Litigation | Bausch + Lomb
Legal proceedings and other matters
Number of defendants | defendant																				19
Number of proceedings | proceeding																				16
PreserVision® AREDS Patent Litigation | Pending Litigation | Subsequent Event | Bausch + Lomb
Legal proceedings and other matters
Number of defendants | defendant	2
PreserVision® AREDS Patent Litigation | Settled Litigation | Bausch + Lomb
Legal proceedings and other matters
Number of defendants | defendant																								12
PreserVision® AREDS Patent Litigation | Default Judgement | Bausch + Lomb
Legal proceedings and other matters
Number of defendants | defendant																								2
Lumify Paragraph I V Proceedings Slayback ANDA Litigation
Legal proceedings and other matters
Stay of approval, period					30 months
Lumify Paragraph I V Proceedings Lupin ANDA Litigation
Legal proceedings and other matters
Stay of approval, period				30 months
Apotex Inc. Litigation | Canada | Pending Litigation
Legal proceedings and other matters
Patents allegedly infringed upon, number | lawsuit																								3
Shower To Shower Product Liability Litigation
Legal proceedings and other matters
Stay of the approval period																		60 days
Stay of approval, motion to extend, period																	60 days
Shower To Shower Product Liability Litigation | Pending Litigation
Legal proceedings and other matters
Number of cases																								26
Shower To Shower Product Liability Litigation | Pending Litigation, Agreed Stipulations Of Dismissal Submitted
Legal proceedings and other matters
Number of cases																								3
Shower To Shower Product Liability Litigation | Canada
Legal proceedings and other matters
Number of cases																								2
Shower To Shower Product Liability Litigation | British Columbia
Legal proceedings and other matters
Number of cases																								1
Shower To Shower Product Liability Litigation | Quebec
Legal proceedings and other matters
Number of cases																								1
Shower To Shower Product Liability Litigation Alleging Caused Ovarian Cancer Mesothelioma Or Breast Cancer | Pending Litigation
Legal proceedings and other matters
Number of cases																								25
Doctors Allergy Formula, LLC Litigation
Legal proceedings and other matters
Damages sought | $																					$ 23,000
Litigation with Former Salix CEO
Legal proceedings and other matters
Damages sought | $													$ 30,000
California Proposition 65 Related Matter Litigation | Subsequent Event
Legal proceedings and other matters
Stay of approval, motion to extend, period one		60 days
Stay of approval, motion to extend, period two		7 days